• Je něco špatně v tomto záznamu ?

A multiparametric heart failure score at baseline is associated with long-term outcome in patients with remotely monitored implantable cardioverter-defibrillators: A pooled analysis of 9 clinical trials

A. D'Onofrio, F. Solimene, A. Bulava, M. Shoda, C. Klein, A. Gargaro, T. Timmel, D. Giacopelli, G. Botto

. 2025 ; 22 (4) : 1055-1063. [pub] 20241009

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009399

BACKGROUND: To predict worsening heart failure hospitalizations (WHFHs), the HeartInsight multiparametric algorithm calculates a heart failure (HF) Score based on temporal trends of physiologic parameters obtained through automatic daily remote monitoring of implantable cardioverter-defibrillators (ICDs). OBJECTIVE: We studied the association of the baseline HF Score, determined at algorithm activation, with long-term patient outcomes. METHODS: Data from 9 clinical trials were pooled, including 1841 ICD patients with a preimplantation ejection fraction ≤35%, New York Heart Association class II/III, and no long-standing atrial fibrillation. The primary end point was a composite of death or WHFH. RESULTS: After a median follow-up of 631 days (interquartile range, 385-865 days), there were 243 WHFHs in 173 patients (9.4%) and 122 deaths (6.6%), 52 of which (42.6%) were cardiovascular. The primary end point occurred in 265 patients (14.4%). A multivariable time-to-first-event analysis showed that a high baseline HF Score (>23, as determined by a time-dependent receiver operating characteristics curve analysis) was significantly associated with the occurrence of the primary end point (adjusted hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.54-2.71; P < .0001), all-cause death (HR, 2.37; CI, 1.56-3.58; P < .0001), cardiovascular death (HR, 2.19; CI, 1.14-4.22; P = .019), and WHFH (HR, 1.91; CI, 1.35-2.71; P = .0003). In a hierarchical event analysis of all-cause death as the outcome with highest priority and WHFHs as repeated event outcomes, the win ratio was 2.47 (CI, 1.89-3.24; P < .0001). CONCLUSION: Based on a retrospective analysis of clinical trial data with adjudicated events, baseline HF Score derived from device-monitored variables was able to stratify patients at higher long-term risk of death or WHFH.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009399
003      
CZ-PrNML
005      
20250429135119.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.hrthm.2024.10.005 $2 doi
035    __
$a (PubMed)39383980
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a D'Onofrio, Antonio $u Unità Operativa di Elettrofisiologia, Studio e Terapia delle Aritmie, Monaldi Hospital, Naples, Italy. Electronic address: donofrioant1@gmail.com
245    12
$a A multiparametric heart failure score at baseline is associated with long-term outcome in patients with remotely monitored implantable cardioverter-defibrillators: A pooled analysis of 9 clinical trials / $c A. D'Onofrio, F. Solimene, A. Bulava, M. Shoda, C. Klein, A. Gargaro, T. Timmel, D. Giacopelli, G. Botto
520    9_
$a BACKGROUND: To predict worsening heart failure hospitalizations (WHFHs), the HeartInsight multiparametric algorithm calculates a heart failure (HF) Score based on temporal trends of physiologic parameters obtained through automatic daily remote monitoring of implantable cardioverter-defibrillators (ICDs). OBJECTIVE: We studied the association of the baseline HF Score, determined at algorithm activation, with long-term patient outcomes. METHODS: Data from 9 clinical trials were pooled, including 1841 ICD patients with a preimplantation ejection fraction ≤35%, New York Heart Association class II/III, and no long-standing atrial fibrillation. The primary end point was a composite of death or WHFH. RESULTS: After a median follow-up of 631 days (interquartile range, 385-865 days), there were 243 WHFHs in 173 patients (9.4%) and 122 deaths (6.6%), 52 of which (42.6%) were cardiovascular. The primary end point occurred in 265 patients (14.4%). A multivariable time-to-first-event analysis showed that a high baseline HF Score (>23, as determined by a time-dependent receiver operating characteristics curve analysis) was significantly associated with the occurrence of the primary end point (adjusted hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.54-2.71; P < .0001), all-cause death (HR, 2.37; CI, 1.56-3.58; P < .0001), cardiovascular death (HR, 2.19; CI, 1.14-4.22; P = .019), and WHFH (HR, 1.91; CI, 1.35-2.71; P = .0003). In a hierarchical event analysis of all-cause death as the outcome with highest priority and WHFHs as repeated event outcomes, the win ratio was 2.47 (CI, 1.89-3.24; P < .0001). CONCLUSION: Based on a retrospective analysis of clinical trial data with adjudicated events, baseline HF Score derived from device-monitored variables was able to stratify patients at higher long-term risk of death or WHFH.
650    _2
$a lidé $7 D006801
650    12
$a defibrilátory implantabilní $7 D017147
650    12
$a srdeční selhání $x terapie $x patofyziologie $x mortalita $7 D006333
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a senioři $7 D000368
650    _2
$a klinické zkoušky jako téma $7 D002986
650    _2
$a následné studie $7 D005500
650    _2
$a algoritmy $7 D000465
650    _2
$a technologie dálkového snímání $x metody $7 D058998
650    _2
$a tepový objem $x fyziologie $7 D013318
650    _2
$a časové faktory $7 D013997
655    _2
$a časopisecké články $7 D016428
700    1_
$a Solimene, Francesco $u Electrophysiology, Montevergine Clinic, Mercogliano, Italy
700    1_
$a Bulava, Alan $u Ceske Budejovice Hospital, Faculty of Health and Social Sciences, University of South Bohemia in Ceske Budejovice, Ceske Budejovice, Czech Republic
700    1_
$a Shoda, Morio $u Clinical Research Division for Heart Rhythm Management, Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan
700    1_
$a Klein, Cedric $u University of Lille, CHU Lille, Lille University Hospital Center, Lille, Hauts-de-France, France
700    1_
$a Gargaro, Alessio $u Clinical Unit, Biotronik Italia S.p.a., Cologno Monzese (MI), Italy
700    1_
$a Timmel, Tobias $u Center for Clinical Research, Biotronik SE & Co KG, Berlin, Germany
700    1_
$a Giacopelli, Daniele $u Clinical Unit, Biotronik Italia S.p.a., Cologno Monzese (MI), Italy
700    1_
$a Botto, Gianluca $u U.O. Electrophysiology, ASST Rhodense, Garbagnate Milanese (MI), Italy
773    0_
$w MED00156180 $t Heart rhythm $x 1556-3871 $g Roč. 22, č. 4 (2025), s. 1055-1063
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39383980 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135115 $b ABA008
999    __
$a ok $b bmc $g 2311027 $s 1246480
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 22 $c 4 $d 1055-1063 $e 20241009 $i 1556-3871 $m Heart rhythm $n Heart Rhythm $x MED00156180
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...